Skip to main content

Logo (Actavis) 347 Pill - red capsule/oblong, 14mm

Pill with imprint Logo (Actavis) 347 is Red, Capsule/Oblong and has been identified as Morphine Sulfate Extended-Release 200 mg. It is supplied by Actavis Pharma, Inc.

Morphine is used in the treatment of Chronic Pain; Neonatal Abstinence Syndrome; Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Morphine 200 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for Logo (Actavis) 347

Morphine sulfate extended-release 200 mg Logo (Actavis) 347
Morphine sulfate extended-release 200 mg Logo (Actavis) 347

Morphine Sulfate Extended-Release

Logo (Actavis) 347
200 mg
14.00 mm
Prescription only
Drug Class
Opioids (narcotic analgesics)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
Inactive Ingredients
lactose anhydrous, magnesium stearate, magnesium silicate, titanium dioxide, ferric oxide red, ferric oxide yellow, polyethylene glycol, cetostearyl alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.